Safety and tolerability of the low global warming potential propellant HFA-152a in patients with asthma receiving beclometasone dipropionate/formoterol fumarate/glycopyrronium: The TRECOS study.
Saved in:
| Title: | Safety and tolerability of the low global warming potential propellant HFA-152a in patients with asthma receiving beclometasone dipropionate/formoterol fumarate/glycopyrronium: The TRECOS study. |
|---|---|
| Authors: | Singh D; Medicines Evaluation Unit an IQVIA business, Manchester, UK; The University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK. Electronic address: dsingh@meu.org.uk., Mancini L; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy., Melis G; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy., Cortellini M; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy., Rostello C; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy., Mathews KS; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy. |
| Source: | Respiratory medicine [Respir Med] 2026 May; Vol. 256, pp. 108814. Date of Electronic Publication: 2026 Apr 06. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3064 (Electronic) Linking ISSN: 09546111 NLM ISO Abbreviation: Respir Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1532-3064 |
|---|---|
| DOI: | 10.1016/j.rmed.2026.108814 |
